Asploro Journal of Pediatrics and Child Health

Article Type: Review Article
DOI: 10.36502/2021/asjpch.6163
Asp J Pediatrics Child Health. 2021 Mar 01;3(1):11-17
Sarah Rotondo-Trivette1, Sonia Michail1,2*
1Keck School of Medicine, University of Southern California, Los Angeles, California
2Children’s Hospital of Los Angeles, Los Angeles, California
Corresponding Author: Sonia Michail, MD, FAAP, AAGAF ORCID iD
Address: Professor of Clinical Pediatrics, Keck School of Medicine, Director of Inflammatory Bowel Disease Research, Children’s Hospital of Los Angeles, 4650 Sunset Blvd MS#78, Los Angeles CA, 90027, USA.
Received date: 31 January 2021; Accepted date: 22 February 2021; Published date: 01 March 2021
Citation: Rotondo-Trivette S, Michail S. Pediatric Inflammatory Bowel Disease. Asp J Pediatrics Child Health. 2021 Mar 01;3(1):11-17.
Copyright © 2021 Rotondo-Trivette S, Michail S. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Inflammatory Bowel Disease, Pediatric Disease, Crohn’s Disease, Ulcerative Colitis, Indeterminate Colitis
Abstract
Inflammatory bowel disease is an important pediatric disease, with as many as 25% of cases presenting during childhood. In this article, we review the types, etiology epidemiology, presentation, diagnosis, and management of pediatric inflammatory bowel disease. We also highlight the unique aspects of pediatric-onset inflammatory bowel disease versus adult-onset and future directions in this field, such as the use of genetic studies and ultrasound for the management of pediatric patients with inflammatory bowel disease.
Key Points
- Pediatric-onset inflammatory bowel disease is unique from adult-onset, and has several different categories based on age of diagnosis.
- Pediatric patients with inflammatory bowel disease may struggle with growth delays and psychosocial impacts of their disease; multidisciplinary management with dietitians and mental health professionals may be warranted.
- HLA typing and the use of ultrasound in pediatric inflammatory bowel disease may mitigate the risk of treatment failure and exposure to invasive procedures over the course of a child’s disease.






